Royalty Pharma plc (MUN:RPD)
Germany · Delayed Price · Currency is EUR 33.50
0.00 (0.00%)
At close: Jan 2, 2026
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of €14.75 billion as of January 9, 2026. Its market cap has increased by 36.74% in one year.
Market Cap
14.75B
Enterprise Value
24.40B
Revenue
2.00B
Ranking
n/a
PE Ratio
22.63
Stock Price
€33.50
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from 14.00B to 14.75B, an increase of 5.39%. That is a compound annual growth rate of 0.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 14.75B | 4.94% |
| Dec 31, 2025 | 14.06B | 28.43% |
| Dec 31, 2024 | 10.95B | -3.17% |
| Dec 29, 2023 | 11.31B | -30.69% |
| Dec 30, 2022 | 16.31B | 8.38% |
| Dec 31, 2021 | 15.05B | -5.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.94B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.01B |